在低收入和中等收入国家预防2型糖尿病的可行性
全球近80%糖尿病患者生活在低收入和中等收入国家(LMICs),近半数未确诊,已知病例临床结局多不理想。LMICs的原发性预防研究显示,在高危人群中可完全预防或延缓糖尿病发生,但证据主要来自亚洲部分国家,尤其是中国和印度。除中国外,此类规划在LMICs的长期有效性尚未得到证实,人群层面预防策略的可行性仍不明确。
要点
- 全球近80%糖尿病患者生活在LMICs,近半数未确诊,已知病例临床结局多不理想。
- LMICs原发预防研究显示,在高危人群中可完全预防或延缓糖尿病发生,具有长期获益。
- 除中国外,此类规划在LMICs的长期有效性尚未得到证实,可行性仍不明确。
核心结论
- 尽管已有证据,LMICs在人群层面预防2型糖尿病的可行性仍不明确。
- 除中国外,此类规划在LMICs的长期有效性尚未得到证实。
- 全球应优先限制糖尿病人群规模,尤其是在LMICs,同时优化已确诊糖尿病患者的照护。
研究设计与样本
- 本文为综述,纳入LMICs中关于2型糖尿病原发性预防的研究证据,并讨论实施机制与挑战。
主要发现
- 全球近80%糖尿病患者生活在LMICs,其中近半数未确诊。
- 多数已知病例的临床结局不理想。
- 大量糖耐量受损和/或空腹血糖受损人群促成2型糖尿病快速增加。
- LMICs原发预防研究显示,在高危人群中可完全预防或延缓糖尿病发生,并具有长期获益,不仅降低2型糖尿病风险,也降低相关代谢紊乱(如心血管疾病)风险。
- 预防证据主要限于亚洲部分国家,尤其是中国和印度。
临床怎么用
- 有效开展国家规划需实施创新机制,如利用信息技术、多团队联合实施类似规划、政府与非政府伙伴关系参与。
- 需持续监测和长期研究评估这些规划的效用。
- 作者指出,全球应优先限制糖尿病人群规模,尤其是在LMICs,同时优化已确诊糖尿病患者的照护。
局限性
- 除中国外,此类规划在LMICs的长期有效性尚未得到证实。
- LMICs预防策略的人群层面可行性仍不明确。
- 存在文化、社会和经济约束方面的挑战。
- 存在基础设施和医疗能力不足的挑战。
- LMICs中2型糖尿病的自然史和决定因素尚未完全阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Type 2 diabetes is a leading cause of global mortality and morbidity. Nearly 80% of individuals with diabetes live in low- and middle-income countries (LMICs), where nearly half of those with the condition remain undiagnosed. The majority of known cases have sub-optimal clinical outcomes. Moreover, large populations with impaired glucose tolerance and/or impaired fasting glucose contribute to the rapid increase in type 2 diabetes. Globally, priority should be given to limit the population with diabetes, especially in LMICs, alongside actions to optimise the care of people diagnosed with diabetes. Primary prevention studies in LMICs have generated evidence to show the efficacy and scalability of strategies to fully prevent or delay the development of diabetes in high-risk groups. However, these are mainly limited to certain countries in Asia, particularly China and India. The studies have indicated that prevention policies are effective in populations with a high risk of type 2 diabetes, and they also have long-term benefits, not only for the risk of type 2 diabetes but also for the risk of associated metabolic disorders, such as CVDs. For the effective conduct of national programmes, innovative mechanisms must be implemented, such as the use of information technology, joint efforts of multiple teams implementing similar programmes, and involvement of governmental and non-governmental partnerships. Continuous monitoring and long-term studies are required to assess the utility of these programmes. The effectiveness of such programmes in LMICs has not been proven over the longer term, except in China. Despite the available evidence, the feasibility of prevention strategies for type 2 diabetes in LMICs at population level remains an enigma. There remain challenges in the form of cultural, societal and economic constraints; insufficient infrastructure and healthcare capacity; and the non-fully elucidated natural history and determinants of type 2 diabetes in LMICs.
引用
- Kengne AP, Ramachandran A. Feasibility of prevention of type 2 diabetes in low- and middle-income countries. Diabetologia. 2024. PMID: 38355989. doi:10.1007/s00125-023-06085-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。